UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d) OFof ~~THE~~

~~SECURITIES~~The ~~EXCHANGE~~Securities ~~ACT~~Exchange OFAct of 1934

Date of Report (Date of earliest event reported): ~~June~~August 18, 2012

AMERICAN RENAL HOLDINGS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

333-170376

04-3477845

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

66 Cherry Hill Drive

Beverly, Massachusetts 01915

(Address of Principal Executive Office)

Registrant’s telephone number, including area code (978) 922-3080

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item 5~~ITEM 2.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Certain~~Financial ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Condition.

AsThe ~~previously~~information ~~disclosed~~contained in aItem 7.01 of this Current Report on Form 8-K ~~filed~~is onincorporated ~~May 18,~~by ~~2012,~~reference onin ~~May 15,~~this 2012, the Boards of Directors (the “Board”) of American Renal Holdings Inc. and American Renal Associates Holdings, Inc. (collectively, the “Company”) elected Joseph A. Carlucci as Chairman of the Board. On JuneItem ~~1, 2012, the Compensation Committee of the Board approved an amendment to Mr~~2. ~~Carlucci’s employment effective May 15, 2012~~02. ~~Such amendment provides the following:~~

•ITEM 7.01 ~~The~~Regulation ~~addition~~FD ~~of the title of Chairman of the Board~~Disclosure.

•On ~~The~~August 8, ~~addition~~2012, ofAmerican ~~$100~~Renal Holdings Inc.,~~000~~ ina ~~compensation~~Delaware ~~paid~~corporation ~~annually~~(the in“Company”), ~~accordance~~announced ~~with~~its financial results for the quarter ended June 30, 2012. A copy of the Company’s ~~customary~~earnings ~~payroll~~press ~~practice~~release is furnished as Exhibit 99.1 to ~~compensate~~this MrCurrent Report on Form 8-K and incorporated by reference in this Item 7.01. ~~Carlucci~~The ~~for~~information ~~his~~contained ~~role~~in asthis ~~Chairman~~Current ofReport on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” with the ~~Board~~Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the Company under the Securities Act of 1933, as amended.

~~• The additional compensation is not considered to be Base Salary for purposes of any bonus paid to Mr~~ITEM 9. ~~Carlucci pursuant to Section 5~~01.2 ofFinancial ~~Mr.~~Statements ~~Carlucci’s Employment Agreement, but is considered to be Base Salary for purposes of any payment due Mr. Carlucci upon termination of his employment (Article 7)~~ and ~~for purposes of computing any payment due Mr~~Exhibits. ~~Carlucci upon the election by the Company to extend the Restrictive Period applicable to the restrictive covenants set forth in Article 8 of the Employment Agreement.~~

~~Item~~(d) 9Exhibits.01 ~~Financial Statements and Exhibits~~

(d) Exhibits


Exhibit Number		Description

99.1		Press Release, dated August 8, 2012.

Exhibit No.		Description
10.1		First Amendment to Employment Agreement among American Renal Management, LLC, American Renal Holdings Inc., American Renal Associates Holdings, Inc. and Joseph A. Carlucci effective as of May 15, 2012
10.2		Employment Agreement between American Renal Management, LLC, American Renal Holdings Inc. and Joseph A. Carlucci dated March 22, 2010 (incorporated by reference to Exhibit 10.6 to the registration statement on Form S-4 filed by American Renal Holdings Inc. on November 4, 2010)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX


Exhibit Number		Description

99.1		Press Release, dated August 8, 2012.

AMERICAN RENAL HOLDINGS INC.

Date: June 6, 2012

/s/ Michael R. Costa

Date: August 8, 2012

/s/ Michael R. Costa

Michael R. Costa Vice President, General Counsel and Secretary

Michael R. Costa

Vice President, General Counsel and Secretary

Filing Compare · American Renal Holdings Inc.